Page last updated: 2024-12-10

2-ethynylaniline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-ethynylaniline: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID4153905
CHEMBL ID394629
SCHEMBL ID170846
MeSH IDM0464877

Synonyms (25)

Synonym
2-ethynylaniline, 98%
2-ethynylaniline
CHEMBL394629
2-ethynylbenzenamine
AKOS005257064
2-ethynyl-phenylamine
52670-38-9
benzenamine, 2-ethynyl-
2-aminophenylacetylene
SCHEMBL170846
2-ethynyl aniline
ALQPJHSFIXARGX-UHFFFAOYSA-N
mfcd00168862
DTXSID30399999
J-508067
CS-W004892
STL554949
n-(2-chloromethyl)-n-methylpiperidine,hydrochloridesalt
AS-10515
AMY23137
BBL101153
SY066830
A847480
E1410
EN300-743880
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID728439Binding affinity to Enterobacteria phage T4 lysozyme L99A/M102H double mutant expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 0.5 mM at pH 6.8 by circular dichroism analysis2013Journal of medicinal chemistry, Apr-11, Volume: 56, Issue:7
The impact of introducing a histidine into an apolar cavity site on docking and ligand recognition.
AID299150Growth inhibition of Verticillium lamellicola at 50 ug/mL2007Bioorganic & medicinal chemistry letters, Apr-01, Volume: 17, Issue:7
Design and synthesis of beta-methoxyacrylate analogues via click chemistry and biological evaluations.
AID728440Binding affinity to Enterobacteria phage T4 lysozyme L99A/M102H double mutant expressed in Escherichia coli BL21(DE3) assessed as change in melting temperature at 0.5 mM at pH 5.4 by circular dichroism analysis2013Journal of medicinal chemistry, Apr-11, Volume: 56, Issue:7
The impact of introducing a histidine into an apolar cavity site on docking and ligand recognition.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (43.75)29.6817
2010's7 (43.75)24.3611
2020's2 (12.50)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.07

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.07 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.60 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.07)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other16 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]